| RECOMMENDATION 11 |
| We recommend the use of intravenous plasma-derived C1 inhibitor as first line short-term prophylaxis. |
| 91% agreement, evidence level C |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.